Breast-Conserving Surgery and Radiotherapy in Early-Stage Breast Cancer: The Importance of Local Control

Seminars in Radiation Oncology

Volumn 21, Issue 1, 2011, Pages 3-9

  Recht, Abram ^a   Solin, Lawrence J ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TAMOXIFEN;

ACUTE TOXICITY; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEBRILE NEUTROPENIA; HUMAN; MULTIPLE CYCLE TREATMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; SKIN TOXICITY; SURVIVAL RATE; SYSTEMIC THERAPY;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL; META-ANALYSIS AS TOPIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL RATE;

EID: 78649861622     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2010.08.001     Document Type: Review

References (45)

1. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 366:2087-2106. Early breast cancer trialists' Collaborative Group.
2. Pass H., Vicini F.A., Kestin L.L. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Cancer 2004, 101:713-720.
3. Cabioglu N., Hunt K.K., Buchholz T.A. Improving local control with breast-conserving therapy: A 27-year single-institution experience. Cancer 2005, 104:20-29.
4. Advances in Breast Cancer Management 2008, Springer, New York, NY. (ed 2). W.J. Gradishar, W.C. Wood (Eds.).
5. Diseases of the Breast 2009, Lippincott Williams & Wilkins, Philadelphia, PA. (ed 4). J.R. Harris, M.E. Lippman, C.K. Osborne (Eds.).
6. The Breast: Comprehensive Management of Benign and Malignant Disorders 2009, Saunders, St Louis, MO. (ed 4). K.I. Bland, E.M. Copeland (Eds.).
7. Darby S. Overview of the randomised trials of radiotherapy in early breast cancer (abstract MS 3-1). Cancer Res 2009, 69(suppl):486s.
8. Darby S.C., McGale P., Taylor C.W. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-565.
9. Harris E.E.R., Correa C., Hwang W.-T. Late cardiac morbidity and mortality in early stage breast cancer patients after breast conservation treatment. J Clin Oncol 2006, 24:4100-4106.
10. Hooning M.J., Botma A., Aleman B.M. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007, 99:365-375.
11. Fisher B., Dignam J., Bryant J. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 1996, 88:1529-1542.
12. Anderson S.J., Wapnir I., Dignam J.J. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 2009, 27:2466-2473.
13. Blamey R.W., Chetty U., Bates T. Radiotherapy and/or tamoxifen after conserving surgery for breast cancer of excellent prognosis: BASO II Trial (Abstract 17) 6 2008, Suppl, EJC, p 55.
14. Winzer K.J., Sauerbrei W., Braun M. Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2x2 randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 2010, 46. 2010.
15. Dalberg K., Johansson H., Johansson U. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Cancer 1998, 82:2204-2211.
16. Fisher B., Bryant J., Dignam J.J. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002, 20:4141-4149.
17. Fisher B., Dignam J., Mamounas E.P. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 1996, 14:1982-1992.
18. Hammer J., Track C., Seewald D.H. Local relapse after breast-conserving surgery and radiotherapy: Effects on survival parameters. Strahlenther Onkol 2009, 185:431-437.
19. Reddy S.G., Kiel K.D. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation. Breast J 2007, 13:12-18.
20. Pierce L.J., Griffith K.A., Hayman J.A. Conservative surgery and radiotherapy for stage. I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys 2005, 61:1317-1327.
21. Fisher B., Dignam J., Wolmark N. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 1997, 89:1673-1682.
22. Fisher B., Redmond C., Legault-Poisson S. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: Results from the National Surgical Adjuvant Breast and Bowel Project B-16. J Clin Oncol 1990, 8:1005-1018.
23. Mamounas E.P., Fisher B., Bryant J. Does delaying breast irradiation in order to administer adjuvant chemotherapy increase the rate of ipsilateral breast tumor recurrence (IBTR)?. Results from two NSABP adjuvant studies in node-positive breast cancer (B-15 and B-16). Breast Cancer Res Treat 1996, 41:219.
24. Fowble B., Fein D.A., Hanlon A.L. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 1996, 35:669-677.
25. Wazer D.E., Morr J., Erban J.K. The effects of postirradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 1997, 80:732-740.
26. Freedman G., Fowble B., Hanlon A. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999, 44:1005-1015.
27. Park C., Mitsumori M., Nixon A. Outcome at 8 years following breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrences. J Clin Oncol 2000, 18:1668-1675.
28. Recht A. Integration of systemic therapy and radiation therapy for patients with early-stage breast cancer treated with conservative surgery. Clin Breast Cancer 2003, 4:104-113.
29. Recht A. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 1996, 334:989.
30. Bellon J.R., Come S.E., Gelman R.S. The sequencing of chemotherapy and radiation therapy in early stage breast cancer: Updated results of a randomized trial. J Clin Oncol 2005, 23:1934-1940.
31. Rouëssé J., de la Lande B., Bertheault-Cvitkovic F. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. Int J Radiat Oncol Biol Phys 2006, 64:1072-1080.
32. Toledano A., Azria D., Garaud P. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. J Clin Oncol 2007, 25:405-410.
33. Toledano A.H., Bollet M.A., Fourquet A. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery?. Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. Int J Radiat Oncol Biol Phys 2007, 68:66-72.
34. Arcangeli G., Pinnaro P., Rambone R. A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. Int J Radiat Oncol Biol Phys 2006, 64:161-167.
35. Bellon J.R., Shulman L.N., Come S.E. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer 2004, 100:1358-1364.
36. Houssami N., Ciatto S., Macaskill P. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26:3248-3258.
37. Houssami N., Hayes D.F. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: Should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA Cancer J Clin 2009, 59:290-302.
38. Katipamula R., Degnim A.C., Hoskin T. Trends in mastectomy rates at the Mayo Clinic, Rochester: Effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009, 27:4082-4088.
39. Bleicher R.J., Ciocca R.M., Egleston B.L. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009, 209:180-187.
40. Pengel K.E., Loo C.E., Teertstra H.J. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: A comparative cohort study. Breast Cancer Res Treat 2009, 116:161-169.
41. Brennan M.E., Houssami N., Lord S. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: Systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 2009, 27:5640-5649.
42. Drew P., Turnbull L., Harvey I. MR imaging in breast cancer-Results of the COMICE trial (abstract 5). Eur J Surg Oncol 2008, 34:1156.
43. Solin L.J., Orel S.G., Hwang W.T. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26:386-391.
44. Hwang N., Schiller D.E., Crystal P. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: Its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 2009, 16:3000-3009.
45. Fischer U., Zachariae O., Baum F. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14:1725-1731.